Regional Veterinary Emergency and Specialty Center, Turnersville, NJ.
National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
Chest. 2018 Feb;153(2):427-437. doi: 10.1016/j.chest.2017.09.041. Epub 2017 Oct 7.
The epidemiology of pneumonia has likely evolved in recent years, reflecting an aging population, changes in population immunity, and socioeconomic disparities.
Using the National (Nationwide) Inpatient Sample, estimated numbers and rates of pneumonia-associated hospitalizations for 2001-2014 were calculated. A pneumonia-associated hospitalization was defined as one in which the discharge record listed a principal diagnosis of pneumonia or a secondary diagnosis of pneumonia if the principal diagnosis was respiratory failure or sepsis.
There were an estimated 20,361,181 (SE, 95,601) pneumonia-associated hospitalizations in the United States during 2001-2014 (average annual age-adjusted pneumonia-associated hospitalization rate of 464.8 per 100,000 population [95% CI, 462.5-467.1]). The average annual age-adjusted pneumonia-associated hospitalization rate decreased over the study period (P < .0001). In-hospital death occurred in 7.4% (SE, 0.03) of pneumonia-associated hospitalizations. Non-Hispanic American Indian/Alaskan Natives and non-Hispanic blacks had the highest average annual age-adjusted rates of pneumonia-associated hospitalization of all race/ethnicities at 439.2 (95% CI, 415.9-462.5) and 438.6 (95% CI, 432.5-444.7) per 100,000 population, respectively. During 2001-2014, the proportion of pneumonia-associated hospitalizations colisting an immunocompromising condition increased from 18.7% (SE, 0.2) in 2001 to 29.9% (SE, 0.2) in 2014. Total charges for pneumonia-associated hospitalizations in 2014 were over $84 billion.
Pneumonia is a major cause of morbidity and mortality in the United States. Differences in rates and outcomes of pneumonia-associated hospitalizations between sociodemographic groups warrant further investigation. The immunocompromised population has emerged as a group experiencing a disproportionate burden of pneumonia-associated hospitalizations.
近年来,肺炎的流行病学可能已经发生了变化,这反映了人口老龄化、人群免疫变化和社会经济差异。
利用国家(全国)住院患者样本,计算了 2001-2014 年与肺炎相关的住院人数和比例。与肺炎相关的住院治疗定义为出院记录中列出肺炎的主要诊断或呼吸衰竭或败血症的次要诊断的住院治疗。
2001-2014 年期间,美国估计有 2036.1181 例(SE,95601)肺炎相关住院治疗(平均每年年龄调整后肺炎相关住院率为 464.8/10 万人口[95%CI,462.5-467.1])。研究期间,平均每年年龄调整后肺炎相关住院率呈下降趋势(P<.0001)。肺炎相关住院患者的院内死亡率为 7.4%(SE,0.03)。非西班牙裔美国印第安人/阿拉斯加原住民和非西班牙裔黑人的肺炎相关住院率为所有种族/民族中最高的,分别为 439.2(95%CI,415.9-462.5)和 438.6(95%CI,432.5-444.7)/10 万人口。2001-2014 年,肺炎相关住院患者并发免疫功能低下疾病的比例从 2001 年的 18.7%(SE,0.2)增加到 2014 年的 29.9%(SE,0.2)。2014 年,肺炎相关住院治疗的总费用超过 840 亿美元。
肺炎是美国发病率和死亡率的主要原因。社会人口统计学群体之间肺炎相关住院率和结果的差异值得进一步研究。免疫功能低下人群已成为肺炎相关住院治疗负担过重的一个群体。